Delivery Order SPE2DB20D3101-SPE2DB26FQTE2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units, valued at $1,384.82 under a firm fixed price contract structure. This delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector vials valued at $3,609.99 with completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed price terms and is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $3,578 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector vials. This competitively awarded, firm fixed-price contract has a completion date of September 9, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,914.68 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xyosted 100 mg/0.5 ml auto-injector units. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,547.87 by the Defense Logistics Agency on June 6, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector units. The contract represents a firm fixed-price delivery order with an ultimate completion date of June 9, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and serves as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies valued at $2,781.88 under a firm fixed-price contract. This non-set-aside award was issued on November 5, 2025, with an ultimate completion date of November 6, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,540.74 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies. This competitively awarded, non-set-aside contract is a firm fixed-price delivery order with a completion date of September 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,334.59 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector units. This is a firm fixed price, competitively awarded delivery order with a completion date of September 24, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Xyosted 50 mg/0.5 mL auto-injector syringes valued at $1,027.18. This firm fixed-price delivery order represents a competitively awarded contract with an ultimate completion date of November 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Xyosted 100 mg/0.5 ml auto-injector medications, with a contract ceiling value of $7,230.62 and an ultimate completion date of October 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB26FQTE2Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector products. This competitively awarded, non-set-aside delivery order carries a ceiling value of $1,105.72 and is structured as a firm fixed price contract with an ultimate completion date of November 5, 2025. The place of performance is designated as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive experience delivering pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of products to support military healthcare programs and other federal government healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/4/25 |